Glatiramer Subcutaneous and Zoladex (Goserelin Implant 3.6 mg)
Determining the interaction of Glatiramer Subcutaneous and Zoladex (Goserelin Implant 3.6 mg) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
Generic Name: goserelin
Brand name: Zoladex
Synonyms: Zoladex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glatiramer Subcutaneous-Zoladex 3-Month
- Glatiramer Subcutaneous-Zoladex Implant
- Glatiramer Subcutaneous-Zolate
- Glatiramer Subcutaneous-Zoledronic acid
- Glatiramer Subcutaneous-Zoledronic Acid (Bone Health)
- Glatiramer Subcutaneous-Zoledronic Acid (Zometa)
- Zoladex (Goserelin Implant 3.6 mg)-Glatopa
- Zoladex (Goserelin Implant 3.6 mg)-Glatopa injection
- Zoladex (Goserelin Implant 3.6 mg)-Glecaprevir and pibrentasvir
- Zoladex (Goserelin Implant 3.6 mg)-Gleevec
- Zoladex (Goserelin Implant 3.6 mg)-Glenmax PEB DM
- Zoladex (Goserelin Implant 3.6 mg)-Glenmax PEB DM FORTE